Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

XTLB

XTL Biopharmaceuticals (XTLB)

XTL Biopharmaceuticals Ltd
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XTLB
FechaHoraFuenteTítuloSímboloCompañía
22/07/202415:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XTLBXTL Biopharmaceuticals Ltd
05/06/202408:15GlobeNewswire Inc.XTL Entered Definitive Agreement to Acquire The Social ProxyNASDAQ:XTLBXTL Biopharmaceuticals Ltd
20/03/202409:15GlobeNewswire Inc.XTL To Aquire The Social ProxyNASDAQ:XTLBXTL Biopharmaceuticals Ltd
20/10/202315:00GlobeNewswire Inc.XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price DeficiencyNASDAQ:XTLBXTL Biopharmaceuticals Ltd
20/10/202315:00GlobeNewswire Inc.XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in IsraelNASDAQ:XTLBXTL Biopharmaceuticals Ltd
16/05/202310:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
01/02/202308:53Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
30/03/202216:16Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
08/06/202105:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
19/05/202110:31Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
24/08/202008:24Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
13/01/202005:39Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
01/11/201809:09PR Newswire (US)XTL Biopharmaceuticals Reports Third Quarter 2018 Financial Results and Provides UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
24/07/201808:09PR Newswire (US)XTL Biopharmaceuticals Reports First Half 2018 Financial Results & Provides UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
29/05/201816:37PR Newswire (US)XTL Biopharmaceuticals Reports First Quarter 2018 Financial Results & Provides UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
07/03/201815:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
28/02/201815:04Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
05/01/201814:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
06/12/201711:08PR Newswire (US)XTL Biopharmaceuticals Ltd. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Listing RequirementsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
27/11/201709:30PR Newswire (US)XTL Biopharmaceuticals Reports Third Quarter 2017 Financial ResultsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
23/10/201710:23PR Newswire (US)XTL Biopharmaceuticals Receives Notification From NASDAQ Regarding Continuing Listing RequirementsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
26/09/201708:23PR Newswire (US)XTL Biopharmaceuticals Reports First Half 2017 Financial Results & Provides Clinical and Operational UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
12/09/201709:24PR Newswire (US)XTL Biopharmaceuticals Unveils Additional Expanded hCDR1 Preclinical Data for the Treatment of Sjogren's SyndromeNASDAQ:XTLBXTL Biopharmaceuticals Ltd
15/06/201708:38PR Newswire (US)XTL Biopharmaceuticals Reports First Quarter 2017 Financial Results & Provides Clinical and Operational UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
27/04/201708:50PR Newswire (US)XTL Biopharmaceuticals Appoints Mr. Alex Rabinovich to its Board of DirectorsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
05/04/201708:10PR Newswire (US)XTL Biopharmaceuticals Unveils Expanded hCDR1 Preclinical Data for the Treatment of Sjögren’s SyndromeNASDAQ:XTLBXTL Biopharmaceuticals Ltd
30/03/201707:55PR Newswire (US)XTL Biopharmaceuticals Reports 2016 Financial Results & Provides Clinical and Operational UpdateNASDAQ:XTLBXTL Biopharmaceuticals Ltd
29/03/201716:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:XTLBXTL Biopharmaceuticals Ltd
22/03/201708:22PR Newswire (US)XTL Biopharmaceuticals Announces Closing of $2.8 Million Private Placement From Existing InvestorsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
07/03/201711:40PR Newswire (US)XTL Biopharmaceuticals Announces $2.8 Million Private Placement From Existing InvestorsNASDAQ:XTLBXTL Biopharmaceuticals Ltd
 Showing the most relevant articles for your search:NASDAQ:XTLB

Su Consulta Reciente

Delayed Upgrade Clock